Login to Your Account


TECFIDERA ROYALTIES POSSIBLE, TOO

DUBLIN – Forward Pharma A/S is banking a $1.25 billion cash payment from Biogen Inc. in a partial settlement of their intellectual property dispute over the use of dimethyl fumarate for treating multiple sclerosis, and it could also be in line to pocket future royalties from sales of Biogen's Tecfidera product.

more »


Our Habitat for All Things Science
Nobel Prize goes for autophagy research

"Basically, it's not easy to define what will serve humanity."

So said Yoshinori Ohsumi, honorary professor at the Tokyo Institute of Technology, after winning the 2012 Kyoto Prize in Life Sciences for his research.

The Nobel Assembly followed suit in recognizing the importance of Ohsumi's work, awarding him the 2016 Nobel Prize in Physiology or Medicine to "for his discoveries of mechanisms for autophagy."

READ MORE »

Opinion


Partners in Focus